跳至主要内容
临床试验/NCT04448951
NCT04448951招募中不适用

Immune Homeostasis in Patients With Sepsis and Septic Shock: a Single Center Observational Study

Charles University, Czech Republic1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Immune response description - flow cytometry

研究概览

简要总结

Detailed description of immune response and its dynamics in sepsis and septic shock patiens by means of transcriptomics, flow-cytometry and cytokine analysis.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • sepsis/septic shock (SEPSIS-3)
  • informed consent
  • inclusion within first 24hrs after development/diagnosis of septic shock

排除标准

  • disagreement of the patient or legal representative with the entry into the study
  • patients with primary or secondary immunodeficiency
  • presence of active haematological malignancy or an active non-haematological malignancy

结局指标

主要结局

Immune response description - flow cytometry

时间窗: 2024 - 2026

Detailed description of immune response analyzed by mean of flow cytometry

Immune response description - ELISA

时间窗: 2024 - 2026

Detailed description of immune response analyzed by mean of ELISA

Immune response description - transcriptomics

时间窗: 2024 - 2026

Detailed description of immune response analyzed by mean of transcriptomic analysis

次要结局

  • Diagnostic "immune status" panel(2026 - 2028)

研究者

发起方
Charles University, Czech Republic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Karvunidis

Principal investigator

Charles University, Czech Republic

研究点 (1)

Loading locations...

相似试验